This Covid portfolio was supposed to take the company to new heights. However, the all-or-nothing strategy has taken Pfizer downhill…
Trendlyne data shows that the BSE stock, comprising nearly 14% of Aggarwal’s portfolio, surged 22% in Q3FY25, driving his net…